What Research Instruments say about themselves
“CooperSurgical: Advancing women's health & fertility solutions. Empowering clinics with innovative tech for better patient outcomes.”
“CooperSurgical: Advancing women's health & fertility solutions. Empowering clinics with innovative tech for better patient outcomes.”
Officer details are public data from the Companies House register.
People and entities with significant control, from the Companies House PSC register
Ownership group derived from the Companies House PSC register
Figures from 2021 accounts. Newer accounts, made up to 31 October 2025, are filed but not read yet. See them on Companies House
| 2021 | 2020 | |
|---|---|---|
| Fixed Assets | £106,986,795 | £107,071,141 |
| Current Assets | £16,854,141 | £16,326,016 |
| Debtors | £4,815,100 | £6,436,991 |
| Cash | £1,469,907 | £1,413,692 |
| Creditors (< 1 year) | £7,794,181 | £7,463,908 |
| Net Current Assets | £9,059,960 | £8,862,108 |
| Net Assets | £115,001,661 | £114,888,155 |
| Shareholder Funds | £115,001,661 | £114,888,155 |
| Turnover | £19,021,049 | £18,715,507 |
| Cost of Sales | £14,370,557 | £12,786,418 |
| Gross Profit | £4,650,492 | £5,929,089 |
| Admin Expenses | £3,118,412 | £2,885,741 |
| Staff Costs | £2,749,554 | £2,880,114 |
| Operating Profit | £976,181 | £2,675,827 |
| Profit Before Tax | £32,242,586 | (£1,739,745) |
| Tax | £2,702,189 | £682,251 |
| Profit for Period | £29,540,397 | (£2,421,996) |
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 10 August 2026 | Full accounts | 31 October 2025 | ||
| 4 August 2026 | Termination of appointment of a director | |||
| 4 August 2026 | Appointment of a director | |||
| 3 August 2026 | Confirmation statement with no updates | 2 August 2026 | ||
| 18 June 2026 | Termination of appointment of a director |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →